Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
103.79
-3.79 (-3.52%)
At close: Jul 13, 2026, 4:00 PM EDT
104.00
+0.21 (0.20%)
After-hours: Jul 13, 2026, 7:42 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $5.06 billion as of July 13, 2026. Its market cap has increased by 1,012.90% in one year.
Market Cap
5.06B
Enterprise Value
5.00B
1-Year Change
1,012.90%
Ranking
Category
Stock Price
$103.79
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $5.06B, an increase of 3,680.02%. That is a compound annual growth rate of 50.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 5.06B | 9.67% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 5.87B |
| Erasca | 5.76B |
| Dianthus Therapeutics | 5.34B |
| Travere Therapeutics | 5.26B |
| CRISPR Therapeutics AG | 5.25B |
| Legend Biotech | 5.24B |
| Oruka Therapeutics | 5.23B |
| Veradermics | 5.00B |